Publication | Closed Access

Radium-223 in the Third-Line Setting in Metastatic Castration-Resistant Prostate Cancer: Impact of Concomitant Use of Enzalutamide on Overall Survival (OS) and Predictors of Improved OS

UrologyOncologyGenitourinary CancerMedicineThird-line SettingCancer ManagementPharmacotherapyCancer TreatmentProstatic DiseasePharmacologyOverall SurvivalImproved Os